Estrella Immunopharma Inc. (NASDAQ: ESLA)
$1.49
-0.0150 ( -1.00% ) 35.2K
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.
Market Data
Open
$1.49
Previous close
$1.50
Volume
35.2K
Market cap
$53.11M
Day range
$1.44 - $1.53
52 week range
$0.81 - $5.62
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jul 02, 2024 |
10-q | Quarterly Reports | 68 | May 15, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
8-k | 8K-related | 44 | Apr 10, 2024 |
8-k | 8K-related | 15 | Mar 11, 2024 |
8-k | 8K-related | 16 | Mar 07, 2024 |
10-q | Quarterly Reports | 69 | Feb 14, 2024 |
8-k | 8K-related | 16 | Feb 02, 2024 |
8-k | 8K-related | 16 | Jan 30, 2024 |
10-q | Quarterly Reports | 67 | Nov 20, 2023 |